China National Ownership

Stocks . China . 
Stock . China National Medicines
600511 Stock   31.92  0.11  0.35%   
China National holds a total of 754.5 Million outstanding shares. China National Medicines retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as China National in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of China National, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China National Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

China Stock Ownership Analysis

About 57.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.45. In the past many companies with similar price-to-book ratios have beat the market. China National Medicines last dividend was issued on the 13th of June 2024. The entity had 20:10 split on the 3rd of June 2009. For more info on China National Medicines please contact the company at 86 10 6727 1828 or go to https://www.cncm.com.cn.

China National Outstanding Bonds

China National issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. China National Medicines uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most China bonds can be classified according to their maturity, which is the date when China National Medicines has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp Bond
US235822AB96		View
Volcan Compania Minera Corp Bond
USP98047AC08		View
Boeing Co 2196 Corp Bond
US097023DG73		View
HSBC Holdings PLC Corp Bond
US404280DR76		View
MPLX LP 4125 Corp Bond
US55336VAK61		View
MPLX LP 52 Corp Bond
US55336VAL45		View
International Game Technology Corp Bond
US460599AD57		View
Morgan Stanley 3591 Corp Bond
US61744YAK47		View

Currently Active Assets on Macroaxis

MSFTMicrosoft
VVisa Class A
CCitigroup
DDDupont De Nemours
GMGeneral Motors

Other Information on Investing in China Stock

China National financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China National security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY